Abbott receives FDA approval for its TactiFlex™ Duo Ablation Catheter to treat people with abnormal heart rhythms
FDA approval catalyst for Abbott’s TactiFlex Duo catheter directly addresses abnormal heart rhythms.
What changed
FDA approval catalyst for Abbott’s TactiFlex Duo catheter directly addresses abnormal heart rhythms.
Why it matters
FDA approval catalyst for Abbott’s TactiFlex Duo catheter directly addresses abnormal heart rhythms. — impact context not separately stored; see What changed.
← Dashboard
Sep 08, 2026 01:06 PM ET